Global CAR T-Cell Immunotherapy Market Insight 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The CAR T-Cell Immunotherapy market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for CAR T-Cell Immunotherapy is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of CAR T-Cell Immunotherapy industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading CAR T-Cell Immunotherapy by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global CAR T-Cell Immunotherapy market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The CAR T-Cell Immunotherapy market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for CAR T-Cell Immunotherapy is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of CAR T-Cell Immunotherapy industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading CAR T-Cell Immunotherapy by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global CAR T-Cell Immunotherapy market are discussed.
The market is segmented by types:
- Monotherapy
- Combination Therapy
- Hematologic Malignancies
- Solid Malignancies
Finally, the report provides detailed profile and data information analysis of leading company.
- AbbVie
- Celgene
- Kite Pharma
- Oxford BioMedica
- Novartis
- Gilead
- Pfizer
- Cellectis
- Bellicum
- Mustang Bio
- CARsgen Therapeutics
- Xyphos
- Minerva Biotechnologies
- Adaptimmune
- Ziopharm Oncology
- Aurora Biopharma
- Creative Biolabs
- xx data tables and xx additional tables
- An overview of global CAR T-Cell Immunotherapy market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the CAR T-Cell Immunotherapy market
- Profiles of major players in the industry, including%li% AbbVie,%li% Celgene,%li% Kite Pharma,%li% Oxford BioMedica,%li% Novartis.....
- To study and analyze the global CAR T-Cell Immunotherapy consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of CAR T-Cell Immunotherapy market by identifying its various subsegments.
- Focuses on the key global CAR T-Cell Immunotherapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the CAR T-Cell Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of CAR T-Cell Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global CAR T-Cell Immunotherapy Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 CAR T-Cell Immunotherapy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 CAR T-CELL IMMUNOTHERAPY INDUSTRY OVERVIEW
2.1 Global CAR T-Cell Immunotherapy Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 CAR T-Cell Immunotherapy Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Market Analysis by Application
2.3.1 Hematologic Malignancies
2.3.2 Solid Malignancies
2.4 Global CAR T-Cell Immunotherapy Revenue, Sales and Market Share by Manufacturer
2.4.1 Global CAR T-Cell Immunotherapy Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global CAR T-Cell Immunotherapy Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 CAR T-Cell Immunotherapy Manufacturer Market Share
2.4.5 Top 10 CAR T-Cell Immunotherapy Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into CAR T-Cell Immunotherapy Market
2.4.7 Key Manufacturers CAR T-Cell Immunotherapy Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 CAR T-Cell Immunotherapy Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
2.7.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
2.7.2 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
2.7.3 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 RELATED MARKET ANALYSIS
3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis
4 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions
4.1.1 Global CAR T-Cell Immunotherapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions (2015-2020)
4.2 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 APAC CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5 EUROPE CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Countries
5.1.1 Europe CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
5.1.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.7 Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.2 Europe CAR T-Cell Immunotherapy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
5.4 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
6 ASIA-PACIFIC CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Countries
6.1.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
6.1.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.3 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.4 Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.5 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.6 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.7 Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
7 NORTH AMERICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
7.1.1 North America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
7.1.2 United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.1.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.1.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.2 North America CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
7.3 North America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
7.4 North America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
8 SOUTH AMERICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
8.1.1 South America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
8.1.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
8.2 South America CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
8.3 South America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
8.4 South America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Countries
9.1.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
9.1.2 GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.3 Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.5 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SEGMENT BY TYPE
10.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2020-2025)
10.3 Monotherapy Revenue Growth Rate
10.4 Combination Therapy Revenue Growth Rate
11 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SEGMENT BY APPLICATION
11.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2015-2020)
11.2 Global CAR T-Cell Immunotherapy Market Forecast by Application (2020-2025)
11.3 Hematologic Malignancies Revenue Growth Rate (2015-2025)
11.4 Solid Malignancies Revenue Growth Rate (2015-2025)
12 MARKET FORECAST FOR CAR T-CELL IMMUNOTHERAPY
12.1 Global CAR T-Cell Immunotherapy Market Size Forecast (2020-2025)
12.2 CAR T-Cell Immunotherapy Market Forecast by Regions (2020-2025)
12.3 Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.4 APAC CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.5 North America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.6 South America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
13 ANALYSIS OF CAR T-CELL IMMUNOTHERAPY INDUSTRY KEY VENDORS
13.1 AbbVie
13.1.1 Company Details
13.1.2 Product Information
13.1.3 AbbVie CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.1.4 Main Business Overview
13.1.5 AbbVie News
13.2 Celgene
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Celgene CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.2.4 Main Business Overview
13.2.5 Celgene News
13.3 Kite Pharma
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.3.4 Main Business Overview
13.3.5 Kite Pharma News
13.4 Oxford BioMedica
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.4.4 Main Business Overview
13.4.5 Oxford BioMedica News
13.5 Novartis
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Novartis CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.5.4 Main Business Overview
13.5.5 Novartis News
13.6 Gilead
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Gilead CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.6.4 Main Business Overview
13.6.5 Gilead News
13.7 Pfizer
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Pfizer CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.7.4 Main Business Overview
13.7.5 Pfizer News
13.8 Cellectis
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Cellectis CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.8.4 Main Business Overview
13.8.5 Cellectis News
13.9 Bellicum
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Bellicum CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.9.4 Main Business Overview
13.9.5 Bellicum News
13.10 Mustang Bio
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.10.4 Main Business Overview
13.10.5 Mustang Bio News
13.11 CARsgen Therapeutics
13.11.1 Company Details
13.11.2 Product Information
13.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.11.4 Main Business Overview
13.11.5 CARsgen Therapeutics News
13.12 Xyphos
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Xyphos CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.12.4 Main Business Overview
13.12.5 Xyphos News
13.13 Minerva Biotechnologies
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.13.4 Main Business Overview
13.13.5 Minerva Biotechnologies News
13.14 Adaptimmune
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.14.4 Main Business Overview
13.14.5 Adaptimmune News
13.15 Ziopharm Oncology
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.15.4 Main Business Overview
13.15.5 Ziopharm Oncology News
13.16 Aurora Biopharma
13.16.1 Company Details
13.16.2 Product Information
13.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.16.4 Main Business Overview
13.16.5 Aurora Biopharma News
13.17 Creative Biolabs
13.17.1 Company Details
13.17.2 Product Information
13.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.17.4 Main Business Overview
13.17.5 Creative Biolabs News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
1 SCOPE OF THE STUDY
1.1 CAR T-Cell Immunotherapy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 CAR T-CELL IMMUNOTHERAPY INDUSTRY OVERVIEW
2.1 Global CAR T-Cell Immunotherapy Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 CAR T-Cell Immunotherapy Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Market Analysis by Application
2.3.1 Hematologic Malignancies
2.3.2 Solid Malignancies
2.4 Global CAR T-Cell Immunotherapy Revenue, Sales and Market Share by Manufacturer
2.4.1 Global CAR T-Cell Immunotherapy Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global CAR T-Cell Immunotherapy Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 CAR T-Cell Immunotherapy Manufacturer Market Share
2.4.5 Top 10 CAR T-Cell Immunotherapy Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into CAR T-Cell Immunotherapy Market
2.4.7 Key Manufacturers CAR T-Cell Immunotherapy Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 CAR T-Cell Immunotherapy Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
2.7.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
2.7.2 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
2.7.3 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 RELATED MARKET ANALYSIS
3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis
4 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions
4.1.1 Global CAR T-Cell Immunotherapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions (2015-2020)
4.2 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 APAC CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5 EUROPE CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Countries
5.1.1 Europe CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
5.1.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.1.7 Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
5.2 Europe CAR T-Cell Immunotherapy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
5.4 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
6 ASIA-PACIFIC CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Countries
6.1.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
6.1.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.3 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.4 Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.5 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.6 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.1.7 Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
7 NORTH AMERICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
7.1.1 North America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
7.1.2 United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.1.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.1.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
7.2 North America CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
7.3 North America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
7.4 North America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
8 SOUTH AMERICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
8.1.1 South America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
8.1.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
8.2 South America CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
8.3 South America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
8.4 South America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA CAR T-CELL IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Countries
9.1.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
9.1.2 GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.3 Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.1.5 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa CAR T-Cell Immunotherapy Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Application (2015-2020)
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SEGMENT BY TYPE
10.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2020-2025)
10.3 Monotherapy Revenue Growth Rate
10.4 Combination Therapy Revenue Growth Rate
11 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET SEGMENT BY APPLICATION
11.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2015-2020)
11.2 Global CAR T-Cell Immunotherapy Market Forecast by Application (2020-2025)
11.3 Hematologic Malignancies Revenue Growth Rate (2015-2025)
11.4 Solid Malignancies Revenue Growth Rate (2015-2025)
12 MARKET FORECAST FOR CAR T-CELL IMMUNOTHERAPY
12.1 Global CAR T-Cell Immunotherapy Market Size Forecast (2020-2025)
12.2 CAR T-Cell Immunotherapy Market Forecast by Regions (2020-2025)
12.3 Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.4 APAC CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.5 North America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.6 South America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
13 ANALYSIS OF CAR T-CELL IMMUNOTHERAPY INDUSTRY KEY VENDORS
13.1 AbbVie
13.1.1 Company Details
13.1.2 Product Information
13.1.3 AbbVie CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.1.4 Main Business Overview
13.1.5 AbbVie News
13.2 Celgene
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Celgene CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.2.4 Main Business Overview
13.2.5 Celgene News
13.3 Kite Pharma
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.3.4 Main Business Overview
13.3.5 Kite Pharma News
13.4 Oxford BioMedica
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.4.4 Main Business Overview
13.4.5 Oxford BioMedica News
13.5 Novartis
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Novartis CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.5.4 Main Business Overview
13.5.5 Novartis News
13.6 Gilead
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Gilead CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.6.4 Main Business Overview
13.6.5 Gilead News
13.7 Pfizer
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Pfizer CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.7.4 Main Business Overview
13.7.5 Pfizer News
13.8 Cellectis
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Cellectis CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.8.4 Main Business Overview
13.8.5 Cellectis News
13.9 Bellicum
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Bellicum CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.9.4 Main Business Overview
13.9.5 Bellicum News
13.10 Mustang Bio
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.10.4 Main Business Overview
13.10.5 Mustang Bio News
13.11 CARsgen Therapeutics
13.11.1 Company Details
13.11.2 Product Information
13.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.11.4 Main Business Overview
13.11.5 CARsgen Therapeutics News
13.12 Xyphos
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Xyphos CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.12.4 Main Business Overview
13.12.5 Xyphos News
13.13 Minerva Biotechnologies
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.13.4 Main Business Overview
13.13.5 Minerva Biotechnologies News
13.14 Adaptimmune
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.14.4 Main Business Overview
13.14.5 Adaptimmune News
13.15 Ziopharm Oncology
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.15.4 Main Business Overview
13.15.5 Ziopharm Oncology News
13.16 Aurora Biopharma
13.16.1 Company Details
13.16.2 Product Information
13.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.16.4 Main Business Overview
13.16.5 Aurora Biopharma News
13.17 Creative Biolabs
13.17.1 Company Details
13.17.2 Product Information
13.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue and Gross Margin (2018-2020)
13.17.4 Main Business Overview
13.17.5 Creative Biolabs News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
LIST OF TABLES AND FIGURES
Figure CAR T-Cell Immunotherapy Picture
Figure Research Programs/Design for This Report
Figure Global CAR T-Cell Immunotherapy Market by Regions (2019)
Table Global Market CAR T-Cell Immunotherapy Comparison by Regions (M USD) 2019-2025
Table Global CAR T-Cell Immunotherapy Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of CAR T-Cell Immunotherapy by Type in 2019
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global CAR T-Cell Immunotherapy Sales by Application (2019-2025)
Figure Global CAR T-Cell Immunotherapy Value Market Share by Application in 2019
Figure Hematologic Malignancies Picture
Figure Solid Malignancies Picture
Table Global CAR T-Cell Immunotherapy Revenue by Vendors (2018-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2019
Table Global CAR T-Cell Immunotherapy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2019
Figure Top 10 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into CAR T-Cell Immunotherapy Market
Table Key Vendors CAR T-Cell Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions in 2019
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure APAC CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure France CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Europe CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 136 Revenue Market Share by Countries in 2019
Figure China CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure India CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table North America CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Manufacturer in 2019
Table South America CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Countries in 2019
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type in 2019
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2020-2025)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2020-2025)
Figure Global Monotherapy Revenue Growth Rate (2015-2025)
Figure Global Combination Therapy Revenue Growth Rate (2015-2025)
Table Global CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application in 2019
Figure Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2020-2025)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2020-2025)
Figure Global Hematologic Malignancies Revenue Growth Rate (2015-2025)
Figure Global Solid Malignancies Revenue Growth Rate (2015-2025)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2020-2025)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) Forecast by Regions (2020-2025)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure North America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure South America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Table AbbVie Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of AbbVie
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure AbbVie CAR T-Cell Immunotherapy Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table Celgene Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Celgene
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Celgene CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Celgene Main Business
Table Celgene Recent Development
Table Kite Pharma Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Kite Pharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Kite Pharma CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Kite Pharma Main Business
Table Kite Pharma Recent Development
Table Oxford BioMedica Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Oxford BioMedica
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Oxford BioMedica CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table Novartis Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Novartis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Novartis CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Gilead Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Gilead
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Gilead CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Gilead Main Business
Table Gilead Recent Development
Table Pfizer Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Pfizer
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Pfizer CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Cellectis Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Cellectis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Cellectis CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Cellectis Main Business
Table Cellectis Recent Development
Table Bellicum Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Bellicum
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Bellicum CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Bellicum Main Business
Table Bellicum Recent Development
Table Mustang Bio Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Mustang Bio
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Mustang Bio CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Mustang Bio Main Business
Table Mustang Bio Recent Development
Table CARsgen Therapeutics Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of CARsgen Therapeutics
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure CARsgen Therapeutics CAR T-Cell Immunotherapy Market Share (2018-2020)
Table CARsgen Therapeutics Main Business
Table CARsgen Therapeutics Recent Development
Table Xyphos Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Xyphos
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Xyphos CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Xyphos Main Business
Table Xyphos Recent Development
Table Minerva Biotechnologies Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Minerva Biotechnologies
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Minerva Biotechnologies CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Minerva Biotechnologies Main Business
Table Minerva Biotechnologies Recent Development
Table Adaptimmune Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Adaptimmune
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Adaptimmune CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Adaptimmune Main Business
Table Adaptimmune Recent Development
Table Ziopharm Oncology Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Ziopharm Oncology
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Ziopharm Oncology CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Ziopharm Oncology Main Business
Table Ziopharm Oncology Recent Development
Table Aurora Biopharma Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Aurora Biopharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Aurora Biopharma CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Aurora Biopharma Main Business
Table Aurora Biopharma Recent Development
Table Creative Biolabs Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Creative Biolabs
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Creative Biolabs CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Creative Biolabs Main Business
Table Creative Biolabs Recent Development
Figure CAR T-Cell Immunotherapy Picture
Figure Research Programs/Design for This Report
Figure Global CAR T-Cell Immunotherapy Market by Regions (2019)
Table Global Market CAR T-Cell Immunotherapy Comparison by Regions (M USD) 2019-2025
Table Global CAR T-Cell Immunotherapy Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of CAR T-Cell Immunotherapy by Type in 2019
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global CAR T-Cell Immunotherapy Sales by Application (2019-2025)
Figure Global CAR T-Cell Immunotherapy Value Market Share by Application in 2019
Figure Hematologic Malignancies Picture
Figure Solid Malignancies Picture
Table Global CAR T-Cell Immunotherapy Revenue by Vendors (2018-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2019
Table Global CAR T-Cell Immunotherapy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2019
Figure Top 10 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into CAR T-Cell Immunotherapy Market
Table Key Vendors CAR T-Cell Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions in 2019
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure APAC CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure France CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Europe CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 136 Revenue Market Share by Countries in 2019
Figure China CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure India CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table North America CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table North America CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Manufacturer in 2019
Table South America CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table South America CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Countries in 2019
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Player (2018-2020)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Player in 2019
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Type (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type in 2019
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2020-2025)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2020-2025)
Figure Global Monotherapy Revenue Growth Rate (2015-2025)
Figure Global Combination Therapy Revenue Growth Rate (2015-2025)
Table Global CAR T-Cell Immunotherapy Revenue by Application (2015-2020)
Table Global CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application (2015-2020)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application in 2019
Figure Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2020-2025)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2020-2025)
Figure Global Hematologic Malignancies Revenue Growth Rate (2015-2025)
Figure Global Solid Malignancies Revenue Growth Rate (2015-2025)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2020-2025)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) Forecast by Regions (2020-2025)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure North America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure South America CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2020-2025)
Table AbbVie Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of AbbVie
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure AbbVie CAR T-Cell Immunotherapy Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table Celgene Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Celgene
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Celgene CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Celgene Main Business
Table Celgene Recent Development
Table Kite Pharma Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Kite Pharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Kite Pharma CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Kite Pharma Main Business
Table Kite Pharma Recent Development
Table Oxford BioMedica Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Oxford BioMedica
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Oxford BioMedica CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table Novartis Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Novartis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Novartis CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Gilead Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Gilead
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Gilead CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Gilead Main Business
Table Gilead Recent Development
Table Pfizer Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Pfizer
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Pfizer CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Cellectis Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Cellectis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Cellectis CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Cellectis Main Business
Table Cellectis Recent Development
Table Bellicum Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Bellicum
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Bellicum CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Bellicum Main Business
Table Bellicum Recent Development
Table Mustang Bio Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Mustang Bio
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Mustang Bio CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Mustang Bio Main Business
Table Mustang Bio Recent Development
Table CARsgen Therapeutics Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of CARsgen Therapeutics
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure CARsgen Therapeutics CAR T-Cell Immunotherapy Market Share (2018-2020)
Table CARsgen Therapeutics Main Business
Table CARsgen Therapeutics Recent Development
Table Xyphos Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Xyphos
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Xyphos CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Xyphos Main Business
Table Xyphos Recent Development
Table Minerva Biotechnologies Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Minerva Biotechnologies
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Minerva Biotechnologies CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Minerva Biotechnologies Main Business
Table Minerva Biotechnologies Recent Development
Table Adaptimmune Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Adaptimmune
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Adaptimmune CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Adaptimmune Main Business
Table Adaptimmune Recent Development
Table Ziopharm Oncology Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Ziopharm Oncology
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Ziopharm Oncology CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Ziopharm Oncology Main Business
Table Ziopharm Oncology Recent Development
Table Aurora Biopharma Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Aurora Biopharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Aurora Biopharma CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Aurora Biopharma Main Business
Table Aurora Biopharma Recent Development
Table Creative Biolabs Company Profile
Figure CAR T-Cell Immunotherapy Product Picture and Specifications of Creative Biolabs
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Creative Biolabs CAR T-Cell Immunotherapy Market Share (2018-2020)
Table Creative Biolabs Main Business
Table Creative Biolabs Recent Development
